Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

MAGE-L2 Activators

MAGE-L2 activators encompass a diverse group of chemical agents capable of upregulating the expression of the MAGE-L2 protein, a member of the melanoma antigen gene family. These chemicals operate through a variety of molecular mechanisms, each engaging with different cellular components and pathways to ultimately enhance the production of MAGE-L2. Some activators work at the genetic level, interacting with the DNA itself or with the proteins that control how tightly DNA is packaged in the nucleus. For instance, epigenetic modifiers like DNA methyltransferase inhibitors may remove methyl groups from the gene's promoter region, a change typically associated with active gene transcription. Histone deacetylase inhibitors, another class of MAGE-L2 activators, can increase the acetylation of histones, proteins around which DNA is wound. This acetylation leads to a more relaxed chromatin structure, allowing transcription machinery better access to the DNA. The result of such epigenetic modulation is an elevated expression of MAGE-L2, with the gene becoming more readily transcribed by the cell's machinery.

Beyond these epigenetic modulators, other chemicals in the class of MAGE-L2 activators may influence protein expression indirectly through the modulation of intracellular signaling pathways. Some activators may function by inhibiting enzymes like proteasomes, which typically degrade proteins, including those that regulate gene expression. The inhibition of proteasomes can lead to the accumulation of transcription factors that specifically enhance the transcription of MAGE-L2. Other members of this chemical class might activate stress response pathways that result in the increased expression of a suite of genes, including MAGE-L2, as part of the cell's adaptive response. Collectively, these activators do not operate in isolation but are part of a dynamic and interconnected network of cellular regulation, each contributing to the modulation of MAGE-L2 expression in distinct but sometimes overlapping ways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Inhibits DNA methyltransferases, potentially demethylating the promoter region of MAGE-L2, leading to its upregulation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Inhibits histone deacetylases, potentially increasing histone acetylation and promoting a more open chromatin structure at the MAGE-L2 locus, facilitating transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Another HDAC inhibitor that may lead to increased histone acetylation at the MAGE-L2 gene, enhancing its transcription.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that may indirectly upregulate MAGE-L2 by altering cellular growth signals and stress responses.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that may upregulate MAGE-L2 through the PI3K/Akt/mTOR signaling pathway.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

A glucocorticoid that could influence MAGE-L2 expression through glucocorticoid response elements if present in the gene's regulatory regions.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

Bromodomain inhibitor that could disrupt protein interactions that repress MAGE-L2 expression, thus potentially upregulating it.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

An HSP90 inhibitor that could destabilize proteins that suppress MAGE-L2 expression, leading to its upregulation.

Anacardic Acid

16611-84-0sc-202463
sc-202463A
5 mg
25 mg
$102.00
$204.00
13
(1)

Potentially increases histone acetylation and transcription of MAGE-L2 by activating histone acetyltransferases.

Geranylgeranylacetone

6809-52-5sc-252851
sc-252851A
10 mg
100 mg
$66.00
$158.00
2
(1)

Induces heat shock proteins that might protect transcription factors involved in MAGE-L2 expression, leading to its upregulation.